Borviz 2 mg Injection
  1. Home
  2. Pharma Products
  3. Intas Pharmaceuticals Ltd
  4. Borviz 2 mg Injection

Borviz 2 mg Injection

Borviz 2 mg Injection contains bortezomib 2 mg and is a proteasome inhibitor used as an anticancer medicine. It is mainly used in the treatment of multiple myeloma and mantle cell lymphoma. The injection is administered by a qualified healthcare professional under specialist medical supervision.

BUY NOW

Category

Bortezomib blocks proteasomes, which are involved in protein breakdown inside cells, leading to accumulation of abnormal proteins and cancer-cell death. It may be used alone or in combination with other anticancer medicines according to the specific treatment protocol. Regular monitoring of blood counts and other clinical parameters is important because treatment may cause low blood-cell counts, peripheral neuropathy, gastrointestinal effects, and other adverse reactions. The dose and administration schedule are individualized by the treating oncologist according to the patient’s condition and treatment response.

Technical Specification

Specification Details
Active Ingredient Bortezomib
Strength 2 mg
Dosage Form Powder for Injection
Route of Administration Intravenous or Subcutaneous
Pack Size 1 Vial
Manufacturer / Marketer Intas Pharmaceuticals Ltd

Product Also Known As

Borviz 2mg Injection, Borviz 2 mg Injection, Bortezomib 2mg Injection, Bortezomib 2 mg Injection, Bortezomib 2mg Vial, Bortezomib Oncology Injection